NEUROGENE Trademark

Trademark Overview

On Wednesday, January 31, 2018, a trademark application was filed for NEUROGENE with the United States Patent and Trademark Office. The USPTO has given the NEUROGENE trademark a serial number of 87777749. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, April 12, 2024. This trademark is owned by NEUROGENE INC.. The NEUROGENE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
neurogene

General Information

Serial Number87777749
Word MarkNEUROGENE
Filing DateWednesday, January 31, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, April 12, 2024
Registration Number5588158
Registration DateTuesday, October 16, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 19, 2018

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 9, 2018
Primary Code042
First Use Anywhere DateTuesday, January 23, 2018
First Use In Commerce DateThursday, February 15, 2018

Trademark Owner History

Party NameNEUROGENE INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNEW YORK, US 10011
Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressNew York, US 10011
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressNew York, US 10011
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressNew York, US 10011

Trademark Events

Event DateEvent Description
Saturday, February 3, 2018NEW APPLICATION ENTERED
Friday, February 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 14, 2018ASSIGNED TO EXAMINER
Tuesday, June 19, 2018PUBLISHED FOR OPPOSITION
Thursday, May 17, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 30, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 19, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 14, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 16, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, August 16, 2018USE AMENDMENT FILED
Wednesday, September 12, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 12, 2018STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 13, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 14, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 16, 2018REGISTERED-PRINCIPAL REGISTER
Friday, December 4, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 4, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 9, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, October 16, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 16, 2023TEAS SECTION 8 & 15 RECEIVED
Friday, April 12, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 12, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 12, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

neurogene fields biotechnology pharmaceutical development research